- $19.39m
- $18.53m
- $0.07m
NASDAQ RESUMED AT 11:06 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:56 AM
NASDAQ RESUMED AT 10:03 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:58 AM
NASDAQ RESUMED AT 09:42 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:37 AM
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: PAVmed Announces Reverse Stock Split
Brief: Pavmed Subsidiary, Veris Health And The Ohio State University Comprehensive Cancer Center Launch Commercial Phase Of Strategic Partnership Agreement
Brief: Lucid Diagnostics Announces Closing Of Public Offering Of Common Stock
Lucid Diagnostics slides on $25 mln stock sale
Brief: Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
Brief: Lucid Diagnostics Announces Proposed Public Offering Of Common Stock
Brief: Pavmed Signs Letter Of Intent To License Groundbreaking Endoscopic Esophageal Imaging Technology
Brief: Lucid Diagnostics Inc QTRLY Loss Per Share $0.08
PAVmed Inc expected to post a loss of 13 cents a share - Earnings Preview
Brief: PAVmed Granted 180-Day Extension By Nasdaq To Regain Compliance With Minimum Bid Price Rule